LION TCR PTE LTD has a total of 12 patent applications. Its first patent ever was published in 2016. It filed its patents most often in China, EPO (European Patent Office) and Republic of Korea. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are INST FOR VIRAL DISEASE CONTROL AND PREVENTION CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION, GALLAGHER GRANT and THE SEC DEP FOR HEALTH.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 2 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | Republic of Korea | 2 | |
#4 | Singapore | 2 | |
#5 | United States | 2 | |
#6 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Peptides | |
#5 | Measuring microorganism processes | |
#6 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Bertoletti Antonio | 12 |
#2 | Koh Sarene | 6 |
#3 | Tanoto Tan Anthony | 6 |
#4 | Ho Zack | 6 |
#5 | Koh Sheau Fung Sarene | 5 |
#6 | Koh Sheau Fung | 1 |
Publication | Filing date | Title |
---|---|---|
KR20190052708A | HBV antigen-specific binding molecules and fragments thereof | |
KR20190006952A | Non-activated T cells expressing an exogenous virus-specific T cell receptor (TCR) |